Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Georgia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Georgia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20111
20121
20171
20181
20201
20211
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Afimmune1
AstraZeneca1
AtheroGenics1
GT Metabolic Solutions, Inc.1
Gilead Sciences1
Inversago Pharma Inc.1
Lexicon Pharmaceuticals1
Metavention1
National Institute of Endocrinology, Georgia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 213
Hypertension3
Diabetes Mellitus2
Heart Failure2
Renal Insufficiency, Chronic2
Angina Pectoris1
Coronary Artery Disease1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1
Hypertriglyceridemia1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.